Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Sensors in Claims: How To Reduce Workplace Injuries
We live in world where almost anything can become or have associated with it a sensor that informs a broader system designed to make the world around us more intelligent, convenient, and very often safer. Consider the Fitbit: according to the company, more than 25 million people worldwide actively used their devices in 2017.
Guidewire Connections 2018
Genex's Sue Ann Knoblauch Wins Platinum Award for Case Management
Two additional Genex case managers recognized as finalistsWAYNE, PA – May 17, 2018 – Genex
StateWatch: Bill Review May 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
Genex receives 2018 Communicator Award for "Robocop: The Jeremy Romero Story"
Video chronicling injured police officer's rise from spinal cord injury recognized by renowned media academy WAYNE, PA - May 16, 2018 - G
Topical Treatments - Their Impact on Drug Spend and Utilization
Topicals place fourth in overall cost among the 10 most expensive drug classes in workers’ comp. These include prescription nonsteroidal anti-inflammatory drugs (NSAIDs) and other formulations, such as creams and patches designed to treat pain.